Last update 08 May 2025

HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication-
Inactive Indication
Hepatitis B, Chronic
Originator Organization
GSK PlcGSK Plc
Active Organization-
Inactive Organization
GSK PlcGSK Plc
License Organization-
Drug Highest PhaseDiscontinuedPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline)
NCT03866187
/ TerminatedPhase 1/2
A first-time-in Human (FTIH), Phase I/II, Randomized, Multi-centric, Single-blind, Controlled Dose-escalation Study to Evaluate the Reactogenicity, Safety, Immunogenicity and Efficacy of GSK Biologicals' HBV Viral Vector Vaccines Given in a Prime-boost Schedule With Sequential or Co-administration of Adjuvanted Proteins Therapeutic Vaccine (GSK3528869A) in Chronic Hepatitis B Patients (18-65 Years Old) Well Controlled Under Nucleo(s)Tide Analogue (NA) Therapy
100 Clinical Results associated with HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline)
Login to view more data
100 Translational Medicine associated with HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline)
Login to view more data
100 Patents (Medical) associated with HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline)
Login to view more data
100 Deals associated with HBc-HBs/AS01B-4 vaccine(GlaxoSmithKline)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 2
United Kingdom
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
Taiwan Province
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
France
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
Thailand
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
Germany
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
Poland
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
Hong Kong
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
Belgium
GSK PlcGSK Plc
28 Mar 2019
Hepatitis B, ChronicPhase 2
Spain
GSK PlcGSK Plc
28 Mar 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free